Janux Therapeutics, Inc. (JANX)
Nasdaq: JANX · CIK 0001817713 · United States
Every official Janux Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open JANX filings
Janux Therapeutics, Inc. documents
- Janux Therapeutics, Inc. 10-K 2026JANX 10-K 2026: annual report for fiscal 2026
- Janux Therapeutics, Inc. 10-K 2025JANX 10-K 2025: annual report for fiscal 2025
- Janux Therapeutics, Inc. 10-K 2024JANX 10-K 2024: annual report for fiscal 2024
- Janux Therapeutics, Inc. 10-K 2023JANX 10-K 2023: annual report for fiscal 2023
- Janux Therapeutics, Inc. 10-K 2022JANX 10-K 2022: annual report for fiscal 2022
- Janux Therapeutics, Inc. 10-Q 2026JANX 10-Q 2026: quarterly report for fiscal 2026
- Janux Therapeutics, Inc. 10-Q 2025JANX 10-Q 2025: quarterly report for fiscal 2025
- Janux Therapeutics, Inc. 10-Q 2024JANX 10-Q 2024: quarterly report for fiscal 2024
- Janux Therapeutics, Inc. 10-Q 2023JANX 10-Q 2023: quarterly report for fiscal 2023
- Janux Therapeutics, Inc. 10-Q 2022JANX 10-Q 2022: quarterly report for fiscal 2022
- Janux Therapeutics, Inc. 8-K 2026JANX 8-K 2026: current report for fiscal 2026
- Janux Therapeutics, Inc. 8-K 2025JANX 8-K 2025: current report for fiscal 2025
- Janux Therapeutics, Inc. 8-K 2024JANX 8-K 2024: current report for fiscal 2024
- Janux Therapeutics, Inc. 8-K 2023JANX 8-K 2023: current report for fiscal 2023
- Janux Therapeutics, Inc. 8-K 2022JANX 8-K 2022: current report for fiscal 2022
- Janux Therapeutics, Inc. DEF 14A 2026JANX DEF 14A 2026: proxy statement for fiscal 2026
- Janux Therapeutics, Inc. DEF 14A 2025JANX DEF 14A 2025: proxy statement for fiscal 2025
- Janux Therapeutics, Inc. DEF 14A 2024JANX DEF 14A 2024: proxy statement for fiscal 2024
- Janux Therapeutics, Inc. DEF 14A 2023JANX DEF 14A 2023: proxy statement for fiscal 2023
- Janux Therapeutics, Inc. DEF 14A 2022JANX DEF 14A 2022: proxy statement for fiscal 2022
- Janux Therapeutics, Inc. Form 4 2026JANX Form 4 2026: insider trading filing for fiscal 2026
- Janux Therapeutics, Inc. Form 4 2025JANX Form 4 2025: insider trading filing for fiscal 2025
- Janux Therapeutics, Inc. Form 4 2024JANX Form 4 2024: insider trading filing for fiscal 2024
- Janux Therapeutics, Inc. Form 4 2023JANX Form 4 2023: insider trading filing for fiscal 2023
- Janux Therapeutics, Inc. Form 4 2022JANX Form 4 2022: insider trading filing for fiscal 2022
- Janux Therapeutics, Inc. S-1 2026JANX S-1 2026: registration statement for fiscal 2026
- Janux Therapeutics, Inc. S-1 2025JANX S-1 2025: registration statement for fiscal 2025
- Janux Therapeutics, Inc. S-1 2024JANX S-1 2024: registration statement for fiscal 2024
- Janux Therapeutics, Inc. S-1 2023JANX S-1 2023: registration statement for fiscal 2023
- Janux Therapeutics, Inc. S-1 2022JANX S-1 2022: registration statement for fiscal 2022
- Janux Therapeutics, Inc. 13F 2026JANX 13F 2026: institutional holdings for fiscal 2026
- Janux Therapeutics, Inc. 13F 2025JANX 13F 2025: institutional holdings for fiscal 2025
- Janux Therapeutics, Inc. 13F 2024JANX 13F 2024: institutional holdings for fiscal 2024
- Janux Therapeutics, Inc. 13F 2023JANX 13F 2023: institutional holdings for fiscal 2023
- Janux Therapeutics, Inc. 13F 2022JANX 13F 2022: institutional holdings for fiscal 2022
More companies